Stock Comparison

CRL vs IDXX

Charles River Laboratories and IDEXX Laboratories Inc side by side — valuation, profitability, growth and risk.

CRL

Charles River Laboratories

Healthcare

IDXX

IDEXX Laboratories Inc

Healthcare

Valuation

Market Cap

$10.39B

$43.50B

P/E (TTM)

—

40.6

Forward P/E

19.4

37.5

Price/Sales

2.6

9.8

Price/Book

3.5

28.0

EV/EBITDA

45.6

28.5

Dividend Yield

—

Profitability

Net Margin

-4.59%

24.60%

Operating Margin

15.90%

31.80%

Return on Equity

-5.87%

72.90%

Return on Assets

4.26%

26.50%

Growth (YoY)

Revenue Growth

1.20%

14.30%

Earnings Growth

-17.30%

17.20%

Price & Risk

Beta

1.4

1.5

52-Week High

$228.88

$769.98

52-Week Low

$144.26

$506.91

Analyst Target

$215.33

$709.14

Compare CRL and IDXX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.